Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 28 min ago
Peer-reviewedCC BY-NC-NDTranslational cancer research

Multi-cohort validation of BRAF-PTPRT co-mutation as a predictor of favorable immunotherapy response in melanoma

  • Dongmei Han1
  • Caihong Wu1
  • Dan Wang1
  • Hao Jin1
  • Weishuai Liu1
  1. 1Center for Precision Cancer Medicine and Translation Research , Tianjin Cancer Hospital Airport Hospital , Tianjin , ;
Read full textPDFCite

Related

  1. Impact of different TP53 mutation subtypes on response and outcome in advanced lung adenocarcinoma receiving first-line immunotherapy or chemo-immunotherapy
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  2. ResponseVerdict overturns computationally validated immunotherapy signatures, recovers their missed responders and outperforms every published response predictor
    H. Jiang, P. Liu, F. Gao +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Targeting Polθ Helicase with RP-3467: Preclinical Validation and Clinical Response in a gBRCA1 ovarian cancer patient with an acquired PARPi resistance mutation in TP53BP1
    A. Sfeir, E. Rosen, M.-C. Mathieu +29
    medRxivPreprintCC BYFull textOncologymedRxiv
  4. Glomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy
    Tomoaki Miyazaki, Yuki Kajio, Akiko Takeshima +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. 445 Co-mutation architecture shapes immunotherapy outcomes in KRAS-mutant NSCLC: real-world evidence from AACR GENIE BPC cohort
    Aayushi Pareek, Saurav Das, Masood Pasha Syed
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYImmunologyOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{han2026multicohort,
  title = {{Multi-cohort validation of BRAF-PTPRT co-mutation as a predictor of favorable immunotherapy response in melanoma}},
  author = {Dongmei Han and Caihong Wu and Dan Wang and Hao Jin and Weishuai Liu},
  journal = {Translational cancer research},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13657813},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Multi-cohort validation of BRAF-PTPRT co-mutation as a predictor of favorable immunotherapy response in melanoma
AU  - Dongmei Han
AU  - Caihong Wu
AU  - Dan Wang
AU  - Hao Jin
AU  - Weishuai Liu
PY  - 2026
DA  - 2026/09/02
JO  - Translational cancer research
UR  - https://europepmc.org/article/PMC/PMC13657813
SN  - 2218-676X
ER  -